Cantor Fitzgerald analyst Mara Goldstein reiterated an Overweight rating and $17 price target on Verastem (NASDAQ: VSTM), saying the capital ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE